Precision medicine

At HIMSS23, panelists discussed how genomics could improve patient care and the challenges to implementing genetic testing programs.

DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

The AI-backed genomic and clinical data company announced it had laid off about 250 workers in August.

The multinational pharma company will now be able to access Tempus' de-identified patient data.

Alphabet's life science arm also announces the company's founder Andy Conrad will step down as CEO. Current president Stephen Gillett will take on the role in January.

The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.

Also: Precision oncology platform OncoHost scores $35 million, home care startup Reverence emerges from stealth with $9.5 million and pediatric behavioral health startup Handspring Health completes a $6.2 million seed round.

Also: Imagene AI raises $21.5 million across two rounds for precision cancer care, and Capable Health scores $6 million in seed funding to help providers build healthcare apps.

Also: Rupa Health raised $20 million for its lab test platform, and CancerIQ scooped up $14 million in Series B funding.